Journal of the American Academy of Dermatology (JAAD)
Published October 30, 2026
00:00
--:--
52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Ato...
October 31, 2026
Share
52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study.
